Manifold: AI-Powered Clinical Research Platform Company Raises $15 Million

By Amit Chowdhry • May 16, 2024

Manifold, an AI-powered clinical research platform, today announced the expansion of its leadership team with veterans of the technology and healthcare industries. Following the $15 million Series A funding round, the expanded team will accelerate Manifold’s ability to automate the manual work of clinical study and data operations alongside its customers, including Indiana University Melvin and Bren Simon Comprehensive Cancer Center and Winship Cancer Institute of Emory University.

These executives are joining Manifold to accelerate the company’s growth:

1.) Chris McMahon joined as Chief People Officer after previously leading the People function at Kyruus Health and Turbonomic through aggressive periods of growth and expansion. Chris will develop and recruit talent, build culture, and oversee people operations.

2.) Alex Akers joins as Vice President of Growth, having previously served as VP of Sales at Health Catalyst as a part of their remarkable growth story, and before that as Director, Strategy and Institutional Partnerships at Grand Rounds. Alex will spearhead growth and expansion efforts across key cancer research centers, leveraging his deep expertise in strategy and market development.

3.) Danielle Kowalski joins as Vice President, Legal, bringing extensive commercial go-to-market and compliance experience to Manifold after spending over 11 years at HubSpot where she most recently served as VP & Deputy General Counsel in their Legal & Compliance function.

4.) Megan Ahigian joins as Senior Director of Product and Partnerships, bringing experience building data-rich products across Healthcare and IT Infrastructure during periods of rapid growth. Megan previously served as VP of Product at Glytec and VP of Product at Kyruus Health.

5.) Taylor Gleason joins as Senior Director of Marketing, bringing deep knowledge of full-funnel marketing strategy in the healthcare technology space, following marketing roles at Kyruus Health, Press Ganey, Amwell, Boston Children’s Hospital, and Cigna.

Manifold also welcomed two go-to-market veterans to its advisory team:

1.) Mike Longo joins as a go-to-market advisor, having previously served as the Vice President of North America R&D Sales at Veeva and an integral part of the leadership team that grew Veeva from its startup stage to over $1 billion in revenue.

2.) Chris Reisig also joins as a go-to-market advisor and brings extensive advisory experience with early-stage technology companies, having led the sales function at companies like Dyn, Turbonomic, Veracode, and Endeca.

Through Manifold, clinical research teams have an advanced and AI-powered, purpose-built platform that makes it possible to enroll and engage study participants, harmonize, and curate longitudinal data, find, and analyze multimodal datasets and collaborate securely across organizations for the first time all in one easy-to-use platform.

KEY QUOTE:

“We’re thrilled to welcome some of the industry’s strongest leaders to help us transform clinical study and data operations with our AI-powered platform. Our team will be crucial to growing our partnerships and expanding our solutions – achieving our vision of making it ten times faster and one-tenth the cost to carry out modern studies and analytics.”

– Vinay Seth Mohta, CEO and Co-Founder of Manifold